HomeNDC LookupRxCUI directory › RxCUI 2588848

Levoketoconazole 150 MG Oral Tablet — RxCUI 2588848

RxNorm drug concept · Semantic clinical drug
RxCUI 2588848 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2588848
Official nameLevoketoconazole 150 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)316 prescriptions · 5 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ketoconazole Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the product you've been given. The shampoo form is used to treat tinea versicolor — a fungal infection that creates lighter or darker blotchy patches, usually on the...
  • What exactly is this medication treating on my skin?
  • This is really common with tinea versicolor, and it doesn't mean the treatment failed. The fungal infection can be cleared up, but the skin takes time to even out its pigment — som...
  • My skin patches haven't gone back to normal color yet — is the treatment even working?
📖 Read our full Ketoconazole Topical guide →

🕸️ Concept Web — How Levoketoconazole 150 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Levoketoconazole 150 MG Oral Tablet RxCUI 2588848

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Ketoconazole 6135
    • Levoketoconazole 2588846
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Recorlev 2588849
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ketoconazole Oral Tablet 372533
    • Levoketoconazole Oral Tablet 2649414
    • Ketoconazole Oral Product 1160954
    • Ketoconazole Pill 1160955
    • Levoketoconazole Oral Product 2660563
    • Levoketoconazole Pill 2660548
    • Ketoconazole Oral Tablet [Recorlev] 2588853
    • Levoketoconazole Oral Tablet [Recorlev] 2655427
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Levoketoconazole 150 MG SCDC · 2588847
  • Ketoconazole Oral Tablet SCDF · 372533
  • Levoketoconazole Oral Tablet SCDFP · 2649414
  • Ketoconazole Oral Product SCDG · 1160954
  • Ketoconazole Pill SCDG · 1160955
  • Levoketoconazole Oral Product SCDGP · 2660563
  • Levoketoconazole Pill SCDGP · 2660548

Brand-Name Concepts

  • Levoketoconazole 150 MG Oral Tablet [Recorlev] SBD · 2588854
  • Levoketoconazole 150 MG [Recorlev] SBDC · 2588850
  • Ketoconazole Oral Tablet [Recorlev] SBDF · 2588853
  • Levoketoconazole Oral Tablet [Recorlev] SBDFP · 2655427
  • Recorlev Oral Product SBDG · 2588851
  • Recorlev Pill SBDG · 2588852
  • Recorlev BN · 2588849

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2588848 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
72065-0003-01 50 TABLET in 1 BOTTLE (72065-003-01) Recorlev Xeris Pharmaceuticals, Inc. 2021-12-30
Observed labelers: Xeris Pharmaceuticals, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.